Bid Publish Date
17-Feb-2026, 12:16 pm
Bid End Date
10-Mar-2026, 12:00 pm
Location
Progress
Quantity
461932
Category
DISPOSABLE INSULIN PEN NEDDLES 4MM
Bid Type
Two Packet Bid
Indian Army invites bids for DISPOSABLE INSULIN PEN NEDDLES 4MM, HYDRALAZINE 37 POINT 5MG PLUS ISOSORBIDE DINITRATE 20 MG TAB, TAB in SOUTH WEST DELHI, DELHI. Quantity: 461932. Submission Deadline: 10-03-2026 12: 00: 00. Submit your proposal before the deadline.
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | DISPOSABLE INSULIN PEN NEDDLES 4MM | Description1 | 1,200 | no | dglp@2023 | 30 |
| 2 | HYDRALAZINE 37 POINT 5MG PLUS ISOSORBIDE DINITRATE 20 MG TAB | Description2 | 6,000 | no | dglp@2023 | 30 |
| 3 | TAB PARACETAMOL 325MG IMMEDIATE RELEASE PLUS PARACETAMOL 675 MG EXTENDED RELEASE | Description3 | 12,300 | no | dglp@2023 | 30 |
| 4 | INTRACAMERAL LIGNOCAINE HYDROCHLORIDE 1 PERCENT WITHOUT PRESERVATIVES FOR INTRAOCULAR USE GLASS AMPULE OF 1 ML | Description4 | 1,200 | amp | dglp@2023 | 30 |
| 5 | INTRACAMERAL PILOCARPINE NITRATE IP 0 POINT 5 WITHOUT PRESERVATIVES FOR INTRAOCULAR USE GLASS AMPULE OF 1 ML | Description5 | 1,800 | amp | dglp@2023 | 30 |
| 6 | INJ FILGRASTIM 300MCG GCSF | Description6 | 48 | vial | dglp@2023 | 30 |
| 7 | CLINIDIPINE 20MG TAB | Description7 | 780 | no | dglp@2023 | 30 |
| 8 | DABIGATRAN 75MG | Description8 | 780 | no | dglp@2023 | 30 |
| 9 | DOXEPIN 10MG CAP | Description9 | 300 | nos | dglp@2023 | 30 |
| 10 | LINAGLIPTIN 2 POINT 5 MG PLUS METFORMIN 1000MG TAB | Description10 | 9,000 | no | dglp@2023 | 30 |
| 11 | SACUBITRIL 97MG PLUS VALSARTAN 103 MG TAB | Description11 | 780 | no | dglp@2023 | 30 |
| 12 | CALCIUM ASPARTATE500MGCALCIUM OROTATE 500 MGCALCITRIOL 0 POINT 25MCG ZINC 7 POINT 5MG MAGNESIUM HYDROXIDE 50MG HYDROXYCOBALAMIN 100MCG FOLIC ACID 1 POINT 5 MG TAB | Description12 | 13,800 | no | dglp@2023 | 30 |
| 13 | FENOFIBRATE 160MG TAB | Description13 | 3,600 | bott | dglp@2023 | 30 |
| 14 | GLYCERIN IP BOTT OF 100 ML | Description14 | 60 | no | dglp@2023 | 30 |
| 15 | HYDROXYZINE 10MG TAB | Description15 | 2,100 | no | dglp@2023 | 30 |
| 16 | ISOSORBID MONONITRATE 30MG TAB | Description16 | 1,500 | no | dglp@2023 | 30 |
| 17 | LEFLUNOMIDE 20 MG TAB | Description17 | 720 | no | dglp@2023 | 30 |
| 18 | LLEVOSULPRIDE 50MG TAB | Description18 | 300 | no | dglp@2023 | 30 |
| 19 | LOSARTAN 50MG PLUS HYDROCHLORTHIAZIDE 12 POINT 5MG TAB | Description19 | 2,400 | no | dglp@2023 | 30 |
| 20 | METADOXINE 500MG TAB | Description20 | 300 | no | dglp@2023 | 30 |
| 21 | METHOTREXATE 10MG TAB | Description21 | 300 | no | dglp@2023 | 30 |
| 22 | METHYLCOBLAMIN 500MCG INJ | Description22 | 1,500 | no | dglp@2023 | 30 |
| 23 | METAOLAZONE 2 POINT 5 MG TAB | Description23 | 300 | no | dglp@2023 | 30 |
| 24 | METAOLAZONE 5 MG TAB | Description24 | 300 | no | dglp@2023 | 30 |
| 25 | PIOGLITAZONE HYDROCHLORIDE 30MG TAB | Description25 | 600 | no | dglp@2023 | 30 |
| 26 | PRAMIPREXOL 0 POINT 25MG SR TAB | Description26 | 300 | no | dglp@2023 | 30 |
| 27 | QUETIAPINE 100 SR MG TAB | Description27 | 600 | no | dglp@2023 | 30 |
| 28 | RESPULES FLUTICASONE 2MG PER ML | Description28 | 600 | no | dglp@2023 | 30 |
| 29 | RIFAXIMIN 200MG TAB | Description29 | 2,400 | no | dglp@2023 | 30 |
| 30 | SIMVASTATIN 10MG TAB | Description30 | 600 | no | dglp@2023 | 30 |
| 31 | AMIODARONE HCL 100MGTAB | Description31 | 1,200 | no | dglp@2023 | 30 |
| 32 | LACOSAMIDE 200MG TAB | Description32 | 600 | no | dglp@2023 | 30 |
| 33 | RAMIPRIL 1 POINT 25 TAB | Description33 | 600 | no | dglp@2023 | 30 |
| 34 | LEVETIRACETAM 250MG TAB | Description34 | 6,000 | no | dglp@2023 | 30 |
| 35 | MEBEVERINE 200MG TAB | Description35 | 600 | no | dglp@2023 | 30 |
| 36 | TIZANIDINE 2 MG TAB | Description36 | 2,400 | no | dglp@2023 | 30 |
| 37 | MONTELUKAST PLUS LEVOCETRAZINE PLUS AMBROXOL 75MG ER TAB | Description37 | 600 | no | dglp@2023 | 30 |
| 38 | CALCIUM ACETATE 435MG PLUS MAGNESIUM CARBONATE 235MG TAB | Description38 | 600 | tab | dglp@2023 | 30 |
| 39 | RIVAROXABAN 20MG TAB | Description39 | 600 | no | dglp@2023 | 30 |
| 40 | GABAPENTIN 100MG CAP | Description40 | 7,200 | no | dglp@2023 | 30 |
| 41 | CALCITROL PLUS CALCIUM PLUS VITAMIN PLUS K 2 TO 7 BORON AND ZINC | Description41 | 1,320 | no | dglp@2023 | 30 |
| 42 | CAP METHYLCOBALAMIN 1500MCG ALPHALIPOIC ACID 100MG FOLIC ACID 1.5MG AND PYRIDOXINE 3MG | Description42 | 7,800 | no | dglp@2023 | 30 |
| 43 | INJ ADRENALINE 0.01 PERCENT INTRA CAMERAL PRESERVATIVE FREE | Description43 | 2,460 | amp | dglp@2023 | 30 |
| 44 | MDI CLICLOSONIDE 200MCG FORMETROL 6MCG TIOTROPIUM 9MCG | Description44 | 60 | no | dglp@2023 | 30 |
| 45 | ACARBOSE 25MG TAB | Description45 | 13,920 | no | dglp@2023 | 30 |
| 46 | TAB TORSEMIDE 10MG SPIRONOLACTONE 25MG | Description46 | 900 | no | dglp@2023 | 30 |
| 47 | BACLOFEN 5MG TAB | Description47 | 3,720 | no | dglp@2023 | 30 |
| 48 | VALSARTAN 40MG TAB | Description48 | 7,320 | no | dglp@2023 | 30 |
| 49 | SYP DICLOMINE DROPS OF 15ML | Description49 | 840 | bottle | dglp@2023 | 30 |
| 50 | ZOLPIDEM TARTRATE 5MG TAB | Description50 | 6,600 | no | dglp@2023 | 30 |
| 51 | POVIDONE IODINE OINT 20GM | Description51 | 3,300 | no | dglp@2023 | 30 |
| 52 | TACROLIMUS 0 POINT 25 MG CAP | Description52 | 300 | no | dglp@2023 | 30 |
| 53 | QUETIAPINE 200 SR MG TAB | Description53 | 600 | no | dglp@2023 | 30 |
| 54 | NEOMYCIN, POLYMYXIN B BACITRACIN POWDER | Description54 | 60 | nos | dglp@2023 | 30 |
| 55 | ED ATROPINE SULPHATE 1 PERCENT W BY V BOTTLE OF 3ML | Description55 | 2,010 | bottle | dglp@2023 | 30 |
| 56 | CEFEPIME PLUS SULBACTUM INJ 1.5GM | Description56 | 600 | vial | dglp@2023 | 30 |
| 57 | EYE OINTMENT NEOSPORIN H NEOMYCIN 3400IU PLUS POLYMYXIN B 5000IU PLUS BACITRACIN 400IU PLUS HYDROCORTISONE 10MG | Description57 | 1,800 | tube | dglp@2023 | 30 |
| 58 | ACECLOFENAC 200MG TAB | Description58 | 6,000 | no | dglp@2023 | 30 |
| 59 | ISOSORBIDE DINITRATE 10 MG TAB | Description59 | 26,220 | no | dglp@2023 | 30 |
| 60 | THIOPENTONE INJ 0 POINT 5 G WITHOUT WATER FOR INJECTION | Description60 | 336 | amp or vial | dglp@2023 | 30 |
| 61 | FLUORESCEIN SODIUM 20 PERCENT 3 ML INJ | Description61 | 180 | amp or vial | dglp@2023 | 30 |
| 62 | LIGNOCAINE VISCOUS 2 PERCENT CONTAINING LIGNOCAINE 21 POINT 3 MG METHYL PARABEN 0 POINT 61 MG PROPYL PARABEN 0 POINT 27 MG PER ML BOTTLE OF 100 ML | Description62 | 846 | bottle | dglp@2023 | 30 |
| 63 | LIGNOCAINE HCL 2 PERCENT WITH ADRENALINE 1 IS TO 80000 30 ML INJ | Description63 | 1,812 | amp or vial | dglp@2023 | 30 |
| 64 | FLUOXETINE HCL 20 MG CAP | Description64 | 67,920 | no | dglp@2023 | 30 |
| 65 | INJ TRIAMCINOLONE 40MG PER ML | Description65 | 120 | no | dglp@2023 | 30 |
| 66 | TAB ALFOZOCIN HYDROCHLORIDE 10MG | Description66 | 7,380 | no | dglp@2023 | 30 |
| 67 | DULOXETINE 20MG TAB | Description67 | 39,000 | no | dglp@2023 | 30 |
| 68 | AMISULPRIDE 100MG TAB | Description68 | 12,000 | no | dglp@2023 | 30 |
| 69 | AMISULPRIDE 50MG TAB | Description69 | 10,800 | no | dglp@2023 | 30 |
| 70 | ENTERAL NUTRITION HEPATIC 100PERCENT HYDROLYSED WHEY PROTEIN CAL DENSITY 1.5 KCALPERML 70PERCENT FAT MCT VEG FOS-1.8-1.9 GMPER100GMCAL460470KCAL FAT1717.5GMPER100GMTIN400GM | Description70 | 30 | no | dglp@2023 | 30 |
| 71 | TRIFLUOPERAZINE 5MG TAB | Description71 | 1,800 | nos | dglp@2023 | 30 |
| 72 | EACH 5ML CONTAINS CHOLECALCIFEROL 6000 IU NANO DROPLET PER 5ML FORM | Description72 | 600 | no | dglp@2023 | 30 |
| 73 | ATENOL 50MG PLUS AMLODIPINE 5MG TAB | Description73 | 22,800 | no | dglp@2023 | 30 |
| 74 | CLOTRIMAZOLE VAGINAL PESSARY 100 MG TAB | Description74 | 26,358 | no | dglp@2023 | 30 |
| 75 | AMLODIPINE BESYLATE 2.5 MG TAB | Description75 | 32,100 | no | dglp@2023 | 30 |
| 76 | ENALAPRIL MALEATE 10 MG TAB | Description76 | 26,880 | no | dglp@2023 | 30 |
| 77 | CYCLOPHOSPHAMIDE 500 MG INJ | Description77 | 360 | vial | dglp@2023 | 30 |
| 78 | DROP ORAL DECONGESTANT DROPS PHENYEPHRINE 5MG CHLORPHENIRAMINE MALEATE 2MGPERMLBOTTLE15MLEQUIVALENT TO T MINIC DROPS | Description78 | 2,640 | no | dglp@2023 | 30 |
| 79 | NEBIVOLOL 5MG TAB | Description79 | 22,320 | no | dglp@2023 | 30 |
| 80 | MICRONISED PROGESTERONE 100 MG INJ | Description80 | 900 | amp | dglp@2023 | 30 |
| 81 | ALOGLIPTIN 25MG TAB | Description81 | 1,950 | nos | dglp@2023 | 30 |
| 82 | CALCIUM 9 MG PLUS CALCIUM GLUCONATE 50 MG INJ FOR IV USE 10 ML INJ | Description82 | 7,230 | amp | dglp@2023 | 30 |
| 83 | BETAMETHASONE 4MG 1 ML INJ | Description83 | 1,800 | vial or amp | dglp@2023 | 30 |
| 84 | DIGOXIN 0 POINT 5 MG 2 ML INJ | Description84 | 792 | amp or vial | dglp@2023 | 30 |
| 85 | INJ FLUORESCEIN DYE 25PERCENT 2ML | Description85 | 150 | vial | dglp@2023 | 30 |
| 86 | INJ AZITHROMYCIN 500 MG | Description86 | 130 | vial | dglp@2023 | 30 |
Discover companies most likely to bid on this tender
Past Performance
Bidder Turnover
OEM Authorization Certificate
Additional Doc 2 (Requested in ATC)
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS